Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with LFCR: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
LFCR
Lifecore Biomedical, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
LFCR
Lifecore Biomedical, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
LLY
3 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±5.1%
▲
+6.63%
×1.29
Q2 FY26
±6.2%
▲
+4.86%
×0.79
Q1 FY26
±5.3%
▲
+9.80%
×1.85
Feb 4 '26
±6.1%
▲
+10.33%
×1.69
LFCR
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±13.6%
▲
+0.31%
×0.02
Q2 FY26
±35.1%
▲
+2.07%
×0.06
= implied
LLY realized, solid
LFCR realized, hatched
One scale, both sides: full bar = 36%
× = |realized| ÷ implied
Source: market data
May 6 '26
±13.3%
▼
−3.88%
×0.29
Q1 FY26
±17.0%
▼
−33.26%
×1.96
LLY
ELI Lilly & Co
Change
1,352.58
▼
−0.89%
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
LFCR
Lifecore Biomedical, Inc.
Change
6.38
▼
−0.30%
Regular session
Nov 6 '26
Mkt cap
$242.6M
Revenue
$25M
Q3 FY26
Revenue
$133M
FY25
vs
Compare
Regular session
Nov 6 '26
LLY
ELI Lilly & Co
vs
LFCR
Lifecore Biomedical, Inc.
1,352.58
▼
−0.89%
Price
6.38
▼
−0.30%
$1.2T
Mkt cap
$242.6M
Q3 FY26
$24.4B
Revenue
$25M
Q3 FY26
FY25
$65.2B
Revenue
$133M
FY25
Change
Change
LLY
1,352.58
▼
−0.89%
vs
LFCR
6.38
▼
−0.30%
Regular session
Nov 6 '26